Aerie Pharmaceuticals (NASDAQ: AERI)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Aerie Pharmaceuticals Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Aerie Pharmaceuticals Company Info
Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company engaged in the discovery development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
News & Analysis
You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you.
Wall Street has given the eye-care specialist the cold shoulder in 2020. Is that an opportunity for individual investors?
Success in clinical trials doesn't guarantee success on the market.
The eye-care company reported better-than-expected fourth-quarter 2019 product revenue.
Disappointing early sales results for its newest treatments, Rhopressa and Rocklatan, haven't shaken the company's confidence. Wall Street is a different story.
Slow sales of its glaucoma drugs is forcing management to cut its sales guidance.
The small-cap company's shares have fallen 64% in the last year, but a promising drug portfolio might signal an opportunity for investors with a long-term mindset.
A new slide deck shows reasons for optimism.
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 04/01/2023.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Earnings Transcripts
AERI earnings call for the period ending September 30, 2021.
AERI earnings call for the period ending June 30, 2021.
AERI earnings call for the period ending September 30, 2020.
AERI earnings call for the period ending June 30, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.